Difference between revisions of "Xu R, et al. JAMA Dermatol. (2016) cited as Ref 759 in DOI: 10.1038/s41392-020-0110-5 (Q10022)"
Jump to navigation
Jump to search
(Created claim: title (P93): The expression status and prognostic value of cancer stem cell biomarker CD133 in cutaneous squamous cell carcinoma, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 305-311, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 305-311 | ||
| Property / Page(s): 305-311 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:51, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Xu R, et al. JAMA Dermatol. (2016) cited as Ref 759 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Xu R
0 references
2016
0 references
JAMA Dermatol.
0 references
152
0 references
The expression status and prognostic value of cancer stem cell biomarker CD133 in cutaneous squamous cell carcinoma (English)
0 references
305-311
0 references
